Adolor Report Sample Clauses

Adolor Report. Within forty-five (45) days after the end of ------------- each Calendar Quarter, on a Collaboration Product-by-Collaboration Product basis in the United States, Adolor shall submit to GSK a written report (each, an "Adolor Report") setting forth in reasonable detail the following items during ------------- such Calendar Quarter: (a) Development Expenses incurred by Adolor for each: (i) Adolor Product; and (ii) the OBD Chronic Product and each other GI Product for where Adolor has elected to fund Development Expenses under Section 4.6.5, and where Adolor has not made a Royalty Conversion Election; (b) Marketing Expenses incurred by Adolor for each: (i) Adolor Product; and (ii) the OBD Chronic Product and each other GI Product for where Adolor has elected to fund Development Expenses under Section 4.6.5, and where Adolor has not made a Royalty Conversion Election; (c) Cost of Goods for each Adolor Product in the United States (except for any Cost of Goods separately reimbursed under a supply agreement between the Parties); (d) Royalties, if any, paid by Adolor to Third Parties in accordance with Section 6.6.1;

Adolor Report. Within ten (10) days after the end of each Calendar Quarter, Adolor shall submit to Pfizer a written report (the “Adolor Report”) setting forth in reasonable detail the following costs and expenses incurred by Adolor in such Calendar Quarter (the “Adolor Expenses”): (a) Development Costs; (b) Adolor Patent Costs, specifying which Adolor Patent Costs relate to Adolor Patents Rights in the ROW and which Adolor Patent Costs relate to Adolor Patents Rights in the U.S.; (c) Sales Expenses, if Adolor is Co-Promoting a Licensed Product in the U.S.; (d) Marketing Expenses, if Adolor is Co-Promoting a Licensed Product in the U.S.; and